Azimuth Pharma Limited
Registered name: AZIMUTH PHARMA LIMITED
Part of Sovereign Capital Partners LLP groupAzimuth Pharma Limited does not publish its revenue or profit. Its accounts to 30 Sep 2024 show net assets of £456k.
Azimuth Pharma Limited did not publish its revenue or profit — small companies aren’t required to file a profit & loss account. Its accounts for the year to 30 Sep 2024 showed net assets of £456k and 0 employees. The company is classified under “activities of head offices” and is based in Macclesfield; we hold 3 years of its filed accounts.
- Status
- Active
- Location
- Macclesfield
- Age
- 14 yrs · since 2012
- Type
- Private Limited Company
Key figures
Revenue not disclosed
Azimuth Pharma Limited’s accounts for the year to 30 Sep 2024 contain a balance sheet but no profit & loss account, so its revenue and profit are not public. UK small and micro-entity companies are not required to publish a P&L — this is normal and says nothing about how the business is performing.
We never estimate revenue. Below you’ll find the balance-sheet figures that were filed — useful as indirect signals of momentum, but they are not revenue or profit.
- Employees
- 0
- Net assets
- £456k
Financial history
| Year to | 30 Sep 2022 | 30 Sep 2023 | 30 Sep 2024 |
|---|---|---|---|
| Disclosure | No P&L | No P&L | No P&L |
| Profit & loss | |||
| Revenue (turnover) | — | — | — |
| Profit (best available) | — | — | — |
| Employees (average) | 0 | 0 | 0 |
| Ratios | |||
| Profit margin | — | — | — |
| Balance sheet — indirect signals, not revenue | |||
| Cash at bank | £94 | £0 | — |
| Net assets | £456k | £456k | £456k |
| Fixed assets | £527k | £527k | £527k |
| Current assets | £94 | £0 | — |
| Source | FullAccounts · bulk data Sep 2024 | FullAccounts · bulk data Sep 2024 | FullAccounts · bulk data Jun 2025 |
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- 0%
- Now £456k
- Cash at bank
- —
- Now —
- Headcount
- —
- Now 0
- Deferred income
- —
- Now —
- Fixed assets
- 0%
- Now £527k
Group structure
Ownership chain
- Sovereign Capital Partners LLPultimate parent75–100%
- BB Shelf 4 LLP75–100%
- Bioscript Holdings Limited75–100%
- Bioscript Midco 1 Limited75–100%
- Bioscript Midco 2 Limited75–100%
- Bioscript Limited75–100%
- Azimuth Pharma Limitedthis company
Bands show the share of ownership each company holds in the one below it.
Subsidiaries (1)
- Fortis Pharma Consulting LimitedRev. £3.4m · Profit £1.7m
Sister companies (5)
- Valid Insight LtdRev. £1.8m · Profit £234k
- Enzyme Communications LtdRev. £1.5m · Profit £362k
- Bioscript Group LimitedRev. — · Profit −£10
- Meridian Healthcomms Holdings LimitedRev. — · Profit −£86k
- Triducive Partners LimitedFigures not disclosed
From the Persons with Significant Control register (corporate controllers only).
Sources
Latest figures from FullAccounts for the year to 30 Sep 2024, from the Companies House accounts bulk data published Jun 2025. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.